Antiviral Agent Therapy Optimization in Special Populations of COVID-19 Patients
Lu Li, Xiaojuan Wang, Rongrong Wang, Yunzhen Hu, Saiping Jiang, Xiaoyang Lu Department of Pharmacy, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, People’s Republic of ChinaCorrespondence: Xiaoyang Lu; Saiping Jiang Email luxiaoyang@zju.edu.cn; j5145@zju...
Saved in:
Main Authors: | Li L (Author), Wang X (Author), Wang R (Author), Hu Y (Author), Jiang S (Author), Lu X (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2020-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The new oral antiviral agents for COVID-19
by: S.L. Seneviratne, et al.
Published: (2022) -
Editorial of Special Column on Antiviral Drug Discovery and Pharmacology
by: Jun Wang, et al.
Published: (2022) -
Antiviral Agents
Published: (2020) -
Effectiveness of Antiviral Drugs as Covid-19 Therapy
by: Adelia Firandi, et al.
Published: (2021) -
IP-10 Interferes With the Antiviral Response of Direct-Acting Antiviral Agents for Hepatitis C Virus Infection
by: Yadong Wang, et al.
Published: (2022)